AI is transforming the IVD industry at every level — from autonomous robotic sample handling and total laboratory automation to AI-powered image analysis in digital pathology and machine learning-driven result interpretation. The AI in diagnostics market is projected to grow at a CAGR exceeding 20% through 2030. Total laboratory automation lines — connecting pre-analytics, analyzers, and post-analytics in a single robotic track — are driving consolidation of analyzer placements toward a small number of dominant suppliers. AI-enabled analyzers from Roche, Siemens Healthineers, and Abbott are reducing manual intervention and enabling laboratory operation with fewer staff. FDA's 2024 guidance now requires encryption and patch management for connected diagnostic devices, raising the compliance bar for smaller competitors.
92 countries — 38 European, 18 Asia-Pacific, 22 Latin American, 11 Middle Eastern, and 3 North American countries.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Topics Covered
• AI and Digital Transformation in IVD Market Size and Forecast 2025-2030
• Total Laboratory Automation — Track Systems, Robotics, and Pre-Analytical Automation
• AI in Image Analysis — Digital Pathology, Hematology Morphology, and Microbiology Imaging
• AI in Result Interpretation — Decision Support, Reflex Testing, and Clinical Alerts
• Autonomous Analyzers — Walkaway Systems, Remote Monitoring, and Predictive Maintenance
• LIS/EHR Connectivity — Middleware, Data Standards, and Interoperability
• Cybersecurity in Connected IVD Devices — FDA Requirements and Implementation
• Competitive Landscape — Leading Automation Suppliers and AI Platform Vendors
• Investment and Partnership Opportunities
'
Table of Contents
1. Executive Summary
- Key findings and strategic implications
- Highest-priority AI and automation opportunities
- Competitive landscape summary
- Strategic recommendations
2. Market Overview
- Market definition, scope and segmentation
- Key demand drivers and restraints
- Regulatory environment — FDA connected device requirements and EU IVDR software rules
3. Total Laboratory Automation
- Track systems, pre-analytics, and middleware integration
- Platform competition — Roche, Siemens Healthineers, Beckman Coulter, and Abbott
- Reagent rental and financial model implications
4. AI in Image Analysis
- Digital pathology and whole slide imaging
- AI-powered hematology morphology and automated blood film review
- Automated microbiology imaging and colony counting
5. AI in Result Interpretation
- Automated flagging, reflex testing, and clinical decision support
- Population health analytics across laboratory networks
- Quality control automation and remote QC management
6. Autonomous Analyzers and Remote Monitoring
- Walkaway systems and unattended laboratory operation
- Remote monitoring platforms and predictive maintenance
- Analyzer-as-a-service commercial models
7. Connectivity and Cybersecurity
- LIS and EHR integration standards
- FDA Software as a Medical Device requirements
- Zero-trust architecture for laboratory networks
8. Competitive Landscape
- Leading automation and AI platform suppliers
- New entrants and healthcare IT companies entering IVD
- M&A and partnership activity 2023-2025
9. Regional Market Analysis
- 9.1 North America (U.S., Canada, Mexico)
- 9.2 Europe (38 countries)
- 9.3 Asia-Pacific (18 countries)
- 9.4 Latin America (22 countries)
- 9.5 Middle East (11 countries)
- 9.6 Africa and Rest of World
10. Strategic Conclusions and Recommendations
- Highest-priority opportunities by segment and region
- Market entry and expansion strategies
- M&A, partnership and investment priorities
11. Appendix
- Research methodology
- Abbreviations and definitions
- List of tables and figures
List of Tables
Table 1. Total Laboratory Automation — Platform Comparison 2025
Table 2. TLA Platform Competition — Roche, Siemens, Beckman Coulter, and Abbott 2025
Table 3. AI in Image Analysis — Application Landscape and Leading Suppliers 2025
Table 4. AI in Result Interpretation — Application Landscape and Leading Suppliers 2025
Table 5. Autonomous Analyzers — Leading Platforms and Capabilities 2025
Table 6. LIS and EHR Connectivity — Adoption by Region and Hospital Segment 2025
Table 7. Cybersecurity and Connected Device Compliance — Regulatory Requirements 2025
Table 8. Leading Suppliers and Competitive Positioning — AI and Automation 2025
Table 9. M&A and Partnership Activity in IVD AI and Automation 2023-2025
Table 10. Key Risks and Mitigation Strategies
Abbott Diagnostics
Bio-Rad Laboratories
bioMérieux
Danaher (Beckman Coulter, Cepheid, Radiometer)
DiaSorin
Hologic
QuidelOrtho
Roche Diagnostics
Siemens Healthineers
Sysmex
